These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9241102)

  • 21. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
    Steinhoff BJ
    Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine.
    Hulsman JA; Rentmeester TW; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Radwanski E; Mojaverian P; Lin CC; Nezamis J
    Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Felbamate.
    Sofia RD; Kramer L; Perhach JL; Rosenberg A
    Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064
    [No Abstract]   [Full Text] [Related]  

  • 24. Felbamate metabolism in pediatric and adult beagle dogs.
    Yang JT; Morris M; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1992; 20(1):84-8. PubMed ID: 1347002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there any future for felbamate treatment?
    Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ
    Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of felbamate in pediatric and adult beagle dogs.
    Adusumalli VE; Gilchrist JR; Wichmann JK; Kucharczyk N; Sofia RD
    Epilepsia; 1992; 33(5):955-60. PubMed ID: 1396441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Felbamate.
    Med Lett Drugs Ther; 1993 Nov; 35(910):107-9. PubMed ID: 8232064
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of felbamate on the pharmacokinetics of lamotrigine.
    Colucci R; Glue P; Holt B; Banfield C; Reidenberg P; Meehan JW; Pai S; Nomeir A; Lim J; Lin CC; Affrime MB
    J Clin Pharmacol; 1996 Jul; 36(7):634-8. PubMed ID: 8844446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.
    Glue P; Banfield CR; Perhach JL; Mather GG; Racha JK; Levy RH
    Clin Pharmacokinet; 1997 Sep; 33(3):214-24. PubMed ID: 9314612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice.
    Borowicz KK; Stasiuk G; Teter J; Kleinrok Z; Gasior M; Czuczwar SJ
    J Neural Transm (Vienna); 2000; 107(7):733-43. PubMed ID: 11005540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aplastic anemia in a patient receiving felbamate for complex partial seizures.
    Pennell PB; Ogaily MS; Macdonald RL
    Neurology; 1995 Mar; 45(3 Pt 1):456-60. PubMed ID: 7898696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New antiepilepsy drug, felbamate, marketed.
    Clin Pharm; 1993 Oct; 12(10):713. PubMed ID: 8258253
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).
    Felbamate Study Group in Lennox-Gastaut Syndrome
    N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.
    White JR; Leppik IE; Beattie JL; Walczak TS; Tran TA; Rarick JO; Vaher P
    Epilepsia; 2009 Nov; 50(11):2390-6. PubMed ID: 19563346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Felbamate reduces hypoxic-ischemic brain damage in vivo.
    Wasterlain CG; Adams LM; Hattori H; Schwartz PH
    Eur J Pharmacol; 1992 Mar; 212(2-3):275-8. PubMed ID: 1601070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of felbamate on valproic acid disposition.
    Wagner ML; Graves NM; Leppik IE; Remmel RP; Shumaker RC; Ward DL; Perhach JL
    Clin Pharmacol Ther; 1994 Nov; 56(5):494-502. PubMed ID: 7955813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectal administration of felbamate in a child with Lennox-Gastaut syndrome.
    Grossmann R; Maytal J; Fernando J
    Neurology; 1994 Oct; 44(10):1979. PubMed ID: 7936261
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of renal impairment on the pharmacokinetics and tolerability of tiagabine.
    Cato A; Gustavson LE; Qian J; El-Shourbagy T; Kelly EA
    Epilepsia; 1998 Jan; 39(1):43-7. PubMed ID: 9578011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of W-554 (ADD 03055) in epileptic patients.
    Wilensky AJ; Friel PN; Ojemann LM; Kupferberg HJ; Levy RH
    Epilepsia; 1985; 26(6):602-6. PubMed ID: 4076064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.